Comparison between Lamosaic India IPO and Onyx Biotec IPO.
Lamosaic India IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
| Lamosaic India IPO | Onyx Biotec IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | MAS Services Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Lamosaic India IPO is up to ₹58.14 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of Lamosaic India IPO is ₹200.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
| Lamosaic India IPO | Onyx Biotec IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹58.00 per share | |
| Issue Price (Upper) | ₹61.00 per share | |
| Issue Price (Final) | ₹200.00 per share | ₹61.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 2000 shares |
| Fresh Issue Size | 29,07,000 shares | 45,66,000 shares |
| Fresh Issue Size (Amount) | up to ₹58.14 Cr | up to ₹27.85 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 29,07,000 shares | 45,66,000 shares |
| Issue Size Total (Amount) | up to ₹58.14 Cr | up to ₹27.85 Cr |
Lamosaic India IPO opens on Nov 21, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Lamosaic India IPO and Onyx Biotec IPO is Nov 26, 2024, and Nov 18, 2024, respectively.
| Lamosaic India IPO | Onyx Biotec IPO | |
|---|---|---|
| Anchor Bid Date | Nov 12, 2024 | |
| Issue Open | Nov 21, 2024 | Nov 13, 2024 |
| Issue Close | Nov 26, 2024 | Nov 18, 2024 |
| Basis Of Allotment (Tentative) | Nov 27, 2024 | Nov 19, 2024 |
| Initiation of Refunds (Tentative) | Nov 28, 2024 | Nov 20, 2024 |
| Credit of Share (Tentative) | Nov 28, 2024 | Nov 20, 2024 |
| Listing date (Tentative) | Nov 29, 2024 | Nov 22, 2024 |
| Anchor Lockin End date 1 | Dec 19, 2024 | |
| Anchor Lockin End date 2 | Feb 17, 2025 |
Lamosaic India IPO P/E ratio is 17.69, as compared to Onyx Biotec IPO P/E ratio of 26.81.
| Lamosaic India IPO | Onyx Biotec IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Lamosaic India Limited Financial Information (Restated)Lamosaic India Limited's revenue increased by 75.25% and profit after tax (PAT) rose by 102.13% between the financial year ending with March 31, 2024 and March 31, 2023.
| Onyx Biotec Limited Financial Information (Restated)Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 88.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.40 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.69 | 26.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹206.76 Cr. | ₹110.61 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 41.36% | 4.99% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 39.95% | 3.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.57 | 1.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.31 | ₹2.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 41.36% | 4.99% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Lamosaic India IPO Retail Individual Investors (RII) are offered 14,53,500 shares while in Onyx Biotec IPO retail investors are offered 14,53,500 shares. Qualified Institutional Buyers (QIB) are offered in Lamosaic India IPO and 9,12,000 shares in Onyx Biotec IPO.
| Lamosaic India IPO | Onyx Biotec IPO | |
|---|---|---|
| Anchor Investor Reserveration | 13,66,000 shares | |
| Market Maker Reserveration | 1,53,000 shares | 2,44,000 shares |
| QIB | 9,12,000 shares | |
| NII | 14,53,500 shares | 6,88,000 shares |
| RII | 14,53,500 shares | 16,00,000 shares |
| Employee | ||
| Others | ||
| Total | 29,07,000 shares | 45,66,000 shares |
Lamosaic India IPO subscribed 1.77x in total, whereas Onyx Biotec IPO subscribed 198.00x.
| Lamosaic India IPO | Onyx Biotec IPO | |
|---|---|---|
| QIB (times) | 32.49x | |
| NII (times) | 0.88x | 602.86x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.66x | 118.26x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.77x | 198.00x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
